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Mutation of ARHGEF18 causes adult-onset retinal degeneration and 
underscores a key role of apicobasal polarity proteins in the 
maintenance of human photoreceptors  
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Abstract 
Over 250 genes are implicated in inherited retinal dystrophy and encode 
proteins involved in a broad spectrum of pathways. Unsolved families 
following highly-parallel sequencing strategies suggest further genes remain 
to be identified. Whole exome and genome sequencing studies employed 
here in large cohorts of affected individuals revealed biallelic mutations in 
ARHGEF18 in three such individuals. ARHGEF18 encodes ARHGEF18 a 
guanine nucleotide exchange factor that activates RHOA, a small GTPase 
protein which is a key component of tight junctions and adherens junctions. 
This biological pathway is known to be important for retinal development and 
function, as mutation of CRB1, encoding another component, causes retinal 
dystrophy. The retinal structure in individuals with ARHGEF18 mutations 
resembled that seen in those with CRB1 mutations. Five mutations were 
found on six alleles in the three individuals, specifically c.808A>G; 
p.Thr270Ala, c.1617+5G>A; p.Asp540Glyfs*63, c.1996C>T; p.Arg666*, 
c.2632G>T; p.Glu878* and c.2738_2761del; p.Arg913_Glu920del. Functional 
tests suggest that each disease genotype might retain some ARHGEF18 
activity, such that the phenotype described here is not the consequence of 
nullizygosity. In particular, the p.Thr270Ala missense allele affects a highly 
conserved residue in the DBL homology domain, which is required for the 
interaction and activation of RHOA. Previously, knock-out of Arhgef18 in the 
medaka fish has been shown to cause larval-lethality which is preceded by 
retinal defects that resemble those seen in zebra fish Crumbs complex knock-
outs. The findings described here emphasise the peculiar sensitivity of the 
retina to perturbations of this pathway, which is highlighted as a target for 
potential therapeutic strategies.  
 
Text 
Inherited retinal dystrophy (IRD) encompasses a clinically and genetically 
heterogeneous group of disorders characterised by retinal dysfunction or 
degeneration. Variants in over 250 genes encoding proteins essential to a 
wide range of biological pathways including mRNA splicing, posttranslational 
protein modification, ciliogenesis, cilia protein transport, retinoid recycling in 
the visual cycle, phototransduction and retinal development, have been found 
causative of IRD (RetNet). 
 
This present report describes mutation of ARHGEF18 (MIM: 616432) as a 
likely cause of human IRD. The gene encodes ARHGEF18 (also known as 
p114RhoGEF)1  the Rho/Rac guanine nucleotide exchange factor 18. It has 
been shown to be involved in the determination of apicobasal (AB) polarity in 
epithelia and cell-cell junction formation through its action on the small 
GTPase RHOA2. The gene is widely expressed, with ESTs identified in many 
human tissues including the neurosensory retina (NCBI-UniGene). 
 
The study protocol adhered to the tenets of the Declaration of Helsinki and 
received approval from the local ethics committee. Written, informed consent 
was obtained from all participants prior to their inclusion in this study. To gain 
further insight into the genetic pathology of inherited retinal dystrophy, whole 
exome sequencing (WES) has been performed on 230 individuals and whole 
genome sequencing (WGS) on a further 599 probands, ascertained from the 
inherited retinal disease clinics at Moorfields Eye Hospital (MEH), London. 
The latter cohort forms part of the NIHR-Bioresource Rare Disease 
consortium in the UK3.  
 
Biallelic mutations in ARHGEF18 were identified in 3 individuals (Table S1), 
presenting as simplex cases, each with a retinal dystrophy sharing features 
with that seen in retinal disease caused by CRB1 (MIM: 604210)4. For this 
reason, in all three individuals, Sanger sequencing of the CRB1 gene had 
been performed but did not identify any potential disease associated variants. 
WGS was performed on individuals 1 and 2; the remaining individual 
(individual 3) underwent WES as previously described5. In the first instance, 
resulting coding variant calls were filtered using a gene list of 236 genes 
previously implicated in retinal dystrophy6. No convincing causal variants were 
identified in these affected individuals (Table S2). 
 
Following WGS, individual 1 (GC18203), a 37 year old female with simplex 
retinitis pigmentosa (RP, MIM: 268000), the 2nd of 2 siblings born to unrelated 
parents with no family history of eye disease, had 20,863 coding (±8bp splice 
region) variants passing standard quality filters. Of these, 360 had a minor 
allele frequency (MAF) ≤0.01 in the publicly available dataset (Exome 
Aggregation Consortium database, ExAC). Assuming autosomal recessive 
inheritance, 5 genes contained ≥2 variants (Table S3). Variants were further 
manually interrogated for variant call quality, MAF in publicly available 
datasets and our own in-house exome sequencing dataset (UCL exome 
project of over 5000 individuals), predicted protein impact and biological 
plausibility (including protein function, expression profile and pathway 
analysis). Of these, two variants were identified in ARHGEF18. The variants, 
a missense and nonsense: GRCh37 (hg19) chr19:g.7509101A>G 
NM_001130955: c.808A>G, p.Thr270Ala ; chr19:g.7527145C>T 
NM_001130955: c.1996C>T, p.Arg666* were absent from ExAC. The 
missense variant (p.Thr270Ala) was predicted to be damaging by in silico 
prediction algorithms (“Sorting the intolerant from tolerant” [SIFT], 
Polymorphism Phenotyping v2 [PolyPhen-2])7,8 and affects a highly conserved 
amino acid residue in the DBL homology (DH) domain (Figure 1).  
 
Identical analysis was performed on the 21,042 coding variants identified by 
WGS in individual 2 (GC3626), a 51 year old male simplex RP affected 
individual, the 2nd of 2 siblings born to unrelated parents with no family history 
of eye disease. Seventeen genes with ≥2 variants (MAF≤0.01) were identified 
(Table S4), among which were two variants comprising a nonsense and in-
frame deletion in ARHGEF18, chr19:g.7532286G>T NM_001130955: 
c.2632G>T, p.Glu878* ; chr19:g.7532392_7532415del 
NM_001130955:c.2738_2761del, p.Arg913_Glu920del. The two variants 
occur within 130bp in exon 16 of ARHGEF18. Interrogation of the 150bp 
paired end reads in this region using the Integrative Genomics Viewer 
(IGV)9,10 allowed phasing of the variants on 7 reads suggesting they were in 
trans (Figure 1c). Familial DNA samples were unavailable for segregation 
analysis. The in-frame deletion of 8 amino acid residues removes part of a 
highly conserved region of the protein (RLEQERAE) (Figure 1d).  
 
Individual 3 (GC17880), an affected individual with simplex RP, the 2nd of 3 
siblings born to 1st cousin parents with no family history of eye disease 
underwent WES revealing 21,404 coding variants. Of these, 383 were rare 
(MAF ≤0.01 in the publicly available NHLBI GO Exome Sequencing Project 
dataset [EVS]). Assuming recessive inheritance due to autozygosity, 7 genes 
had homozygous variants affecting the canonical transcript (Table S5), 6 of 
which were located within homozygous regions ≥5Mb identified by prior SNP 
array autozygosity mapping data (SNP6, Affymetrix). Of these variants, a 
splice region substitution (chr19:g.7521294G>A NM_001130955: 
c.1617+5G>A) in ARHGEF18 was the most compelling candidate. This 
variant is predicted to weaken the canonical splice donor site and lead to out 
of frame skipping of ARHGEF18 exon 8.  
 
The variants in each individual were confirmed to be biallelic by familial 
segregation analysis in all available relatives (Figure 1a); no unaffected family 
member available for screening carried two disease alleles. Subsequent direct 
Sanger sequencing of all coding exons of ARHGEF18 in 10 individuals with a 
similar phenotype and no detectable mutation in CRB14 revealed no further 
mutations in ARHGEF18. In a cohort of 5695 individuals who underwent WES 
(UCL-exome cohort), no rare (MAF≤0.01) loss of function (LOF) variants were 
identified, 4 individuals with unrelated phenotypes had predicted biallelic rare 
missense variants (Table S6). 
 
The affected individuals reported here all presented in their 3rd – 4th decades 
with central visual disturbance, visual field defects and mild nyctalopia (Table 
S7). At last review at ages 37, 51 and 38 years for individuals 1, 2 and 3 
respectively, visual acuity ranged from 0.18 log MAR (Snellen 20/30) to 1.8 
log MAR (Snellen 20/1250) being worst in the oldest individual. Fundus 
examination revealed optic disc pallor, attenuated retinal vessels and irregular 
mid-peripheral intra-retinal pigment migration. Fundus autofluorescence (FAF) 
imaging revealed widespread, irregular, peripheral hypo-autofluorescence 
(Figure 2). Optical coherence tomography (OCT) demonstrated intra-retinal 
cysts in all affected individuals. Such imaging produces an in vivo cross-
section of the retina. A useful landmark to gauge the degree of retinal 
degeneration is a contiguous line, parallel with the inner retinal surface, which 
is thought to be formed by reflection from mitochondria in photoreceptor inner 
segments, the so-called inner-segment ellipsoid line (ISe)11 Individuals 1 and 
3 had a preserved ISe throughout the macula; for Individual 2 the ISe was 
retained only in the foveal region. The irregularity of the autofluorescence is 
distinct from that occurring in primary rod photoreceptor disease and instead 
resembles that seen in CRB1-retinopathy. Moreover, peripheral nummular 
pigment was similar to CRB1-retinopathy. In most degenerative dystrophies 
the retina is thinner than normal, and in these individuals retinal thickness 
instead resembled that seen in CRB1-retinopathy. Full-field 
electroretinography (ERG), performed in all individuals at a similar age (29-30 
years)12, demonstrated severe generalized retinal dysfunction affecting rod 
more than cone photoreceptors (Figure S1). The pattern ERG13 was 
subnormal in individuals 1 and 3, indicating relatively mild macular 
involvement, but was undetectable in individual 2 consistent with severe 
macular involvement. There was no clinical evidence of other systemic, 
neurological or other epithelial disease in any of the individuals. 
 
Cell-cell junctions, (Tight junctions [TJ] and adherens junctions [AJ]) are 
important in the establishment of apicobasal (AB) polarity. During vertebrate 
eye morphogenesis, AB polarity of epithelial cells forming the optic vesicle is 
established and maintained by the migration and accumulation of specific 
polarity proteins and lipid complexes and the regulation of actomyosin 
network in distinct apical and basal membrane domains and the formation of 
TJ and AJ14,15. Interkinetic nuclear migration (IKNM) along the AB polarity axis 
results in specific positioning of nuclei in the single-cell neuroepithelium and a 
pseudostratified appearance, and in turn contributes to the cell fate 
determination during differentiation into the 3 nuclear layers of the retina16.  
 
Three major classes of protein complexes have been implicated in the 
establishment and maintenance of AB polarity: the Crumbs, Par and Scribble 
complexes that serve as either apical or basolateral determinants. Rho small 
GTPase family members RHOA, RAC1 and CDC42 are central to the 
regulation of cell migration, contact adhesion and the regulation of these 
apical and basolateral derterminants15. The genes encoding these GTPase 
family members have not been implicated in retinal disease15,17. The 
activation status of Rho GTPases is determined by the guanine nucleotide 
bound to them (GTP-active, GDP-inactive), which is, in turn, regulated by 
guanine nucleotide exchange factors (GEF) and GTPase activating proteins 
(GAP).  
 
Regulation of RHOA activation through ARHGEF18 is important for tissue 
morphogenesis and migration, and in the assembly and maintenance of cell-
cell junctions, TJ and AJ14,15. Cell junctions form intracellular connections 
essential for control of cell proliferation and morphology, and maintenance of 
tissue integrity. In epithelia, TJs are formed at the apical/lateral border and 
control the movement of molecules along the paracellular space18. Molecular 
mechanisms regulating RHOA activation are crucial components of the 
pathways that guide TJ assembly and function. ARHGEF18 drives RHOA 
activation at TJs and thereby regulates actomyosin activity and TJ assembly, 
epithelial morphology and dynamics2,19,20. 
 
Cell-cell junctions and AB polarity are essential in the function and 
maintenance of retinal architecture21,22. In particular, the outer limiting 
membrane (OLM) is formed of AJs between Müller glia cells and 
photoreceptors and the inner/outer segments of photoreceptors are formed 
from the apical membrane of developing photoreceptors.  
 
All of the individuals harbored genotypes of ARHGEF18 that might 
conceivably produce some protein function, rather than being definite biallelic 
nulls. Individuals 1 and 2 had a nonsense mutation in trans with a missense or 
inframe deletion respectively. Reverse transcription-PCR (RT-PCR) and direct 
sequencing analysis of the ARHGEF18 transcript from lymphocytes of 
individual 3 (c.1617+5G>A) using PCR primers spanning exon 6-9 identified 
differently spliced transcripts (Figure S2). Direct sequencing of the PCR-
generated products identified a short transcript lacking exon 8 and a weaker 
band corresponding to the wild type (WT) transcript (including exon 8). Hence, 
a low proportion of WT transcript and full length WT protein is likely to be 
produced despite this splice-site alteration. Guanine to adenine transitions at 
position +5 in splice donor sites are recognised pathogenic mutations but 
have been reported previously to produce some normal mRNA product, for 
example in the context of cystic fibrosis 23. The downstream consequence of 
exon 8 skipping would be a termination codon following 62 out of frame 
codons (p.Asp540Glyfs*63) and a transcript that is likely to undergo nonsense 
mediated decay (NMD). The inframe deletion in individual 2, is predicted to 
abolish several putative exonic splice enhancer (ESE) motifs24. However, RT-
PCR and direct sequencing of the ARHGEF18 transcript from lymphocytes of 
individual 2 using PCR primers spanning exon 13-17 identified no alteration in 
splicing (Figure S2) as a consequence of the deletion. 
 
In order to determine the functional consequence and potential pathogenicity 
of the missense and inframe deletion variants, HEK293T cells were 
transfected with expression vectors encoding wild-type (WT) ARHGEF18 
(NM_001130955)2 or with the p.Thr270Ala substitution or the 
p.Arg913_Glu920del deletion generated using the Q5 site-directed 
mutagenesis kit (New England Biolabs, Hitchin, UK) according to 
manufacturers instructions and propagated, purified and sequenced using 
standard procedures. A previously characterized catalytically inactive mutant 
was included as a control (p.Tyr418Ala, previously referred to as 
p.Tyr260Ala)2. RHOA activation is essential for ARHGEF18 to stimulate TJ 
assembly. This was tested by measuring RHOA-GTP levels in transfected 
HEK293T cells using a biochemical 96-well assay that measures binding of 
RHOA-GTP to the Rho binding domain of Rhotekin (G-LISA, Cytoskeleton, 
Inc.; 2). Ectopic expression of the WT protein led to a more than 5-fold 
stimulation of RHOA-GTP levels (Figure 3A). The p.Thr270Ala mutant 
retained some activity compared to the catalytically inactive p.Tyr418Ala 
construct as it led to a 3-fold increase in RHOA-GTP levels, but was less than 
50% of the WT level (Figure 3A). The deletion mutant (p.Arg913_Glu920del) 
had a similar increase in RHOA-GTP level to the WT protein (Figure 3A).  
 
The transcriptional activity of serum response factor (SRF) was measured in 
transfected cells using a double luciferase reporter assay25 to monitor 
signalling output of the mutant ARHGEF18 constructs. Similar to the RHOA 
activation assay, the WT construct led to a strong stimulation of SRF-driven 
luciferase expression while the missense mutant (p.Thr270Ala) led to a 3-fold 
reduction in the level of luciferase expression but, as in the RHOA-GTP 
assay, showed significant activity also if compared to the inactive p.Tyr418Ala 
mutant; the deletion mutant (p.Arg913_Glu920del) level was unaltered (Figure 
3B). Thus, the p.Thr270Ala mutant led to reduced but not abolished RHOA 
activation and signalling, and the p.Arg913_Glu920del mutant did not affect 
RHOA activation.  
 
As ARHGEF18 stimulates cortical actomyosin activation leading to TJ 
assembly and cell rounding in epithelial cells, human corneal epithelial cells 
(HCE) were transfected with the WT or mutant expression vectors, including 
the p.Tyr418Ala catalytically inactive control. Transfection of WT but not the 
p.Tyr418Ala control led to rounded morphology of the normally flat cells, 
increased cortical phospho-myosin (pp-MLC) and F-actin staining (Figure 3C). 
Similar to the GEF inactive mutant (p.Tyr418Ala), the p.Thr270Ala mutant was 
not recruited to the cell cortex and failed to induce the cortical actomyosin 
cytoskeleton enrichment (Figure 3C), supporting the conclusion that its activity 
was strongly reduced. The deletion mutant (p.Arg913_Glu920del) induced 
some cortical actomyosin reorganization, but appeared to do so less 
efficiently than WT. In addition, its distribution was more patchy and irregular 
than WT. Both mutations thus affect the normal subcellular localization of 
ARHGEF18. Only the WT protein induced a strong stimulation of recruitment 
of junctional proteins when overexpressed (Figure 3D). The two point 
mutations (p.Thr270Ala, p.Tyr418Ala) failed to induce a response, and the 
deletion mutation led to cell rounding but only a weak increase in junctional 
recruitment of TJ markers alpha-catenin and Catenin delta-1, suggesting that 
the deletion inhibits the normal cellular activity of ARHGEF18 despite showing 
normal catalytic activity. 
 
The missense mutation p.Thr270Ala resides within the DH domain of 
ARHGEF18, which is the catalytic domain required for guanine nucleotide 
exchange26. Thr270 is located within the first alpha-helix of the highly 
conserved DH domain. This residue is conserved as a threonine or serine in 
virtually all DH domains throughout nature. In the C.elegans Rac GTPase 
activating protein, UNC-73, serine or threonine at this residue maintain the 
catalytic activity whereas mutation to alanine abolishes its activity26,27. The 
hydroxyl group of the serine or threonine at this position in the DH domain is 
thought to mediate GTPase interaction, hence, substitution of Thr270 of 
ARHGEF18 may inhibit RHOA activation in this way.  
 
The inframe deletion occurs in exon 16, downstream of the DH and PH 
module and does not directly interfere with the catalytic activity. The STK11 
binding domain has been mapped to the C-terminal region of the murine 
ARHGEF18 protein encompassing these deleted amino acid residues and 
interaction of STK11 and ARHGEF18 is essential in AJ formation28. Despite 
being catalytically active, the inframe deletion mutant appeared less potent for 
induction of cortical actomyosin organisation than the WT GEF, suggesting 
that the deletion may indeed affect interactions required for normal cellular 
ARHGEF18 function, possibly by removing residues required for interactions 
or for normal folding of the C-terminal domain. 
 
The data indicate that all affected individuals retain some exchange factor 
activity or native protein. The strong reduction of ARHGEF18 function 
observed leads to the development of retinal dystrophy in these individuals 
but heterozygous carriers of LOF mutations are unaffected. The absence of a 
confirmed biallelic null in the cohort or indeed in the ExAC dataset suggests 
complete loss of ARHGEF18 function could be developmentally severe or 
lethal or may have a more syndromic phenotype. The hypothesis of an 
embryonic lethal phenotype is supported by the effect of null alleles in 
medaka fish29.  
 
Perturbation of the AB polarity of epithelial cells is recognised in 
tumorigenesis and cancer progression17,30,31 but, to date, only CRB1 of the AB 
polarity complex encoding genes32 has been implicated in human Mendelian 
disease. Mutation of CRB1 causes a wide spectrum of retinal disease 
including Leber congenital amaurosis (LCA), early onset retinal dystrophy 
(EORD), RP and more recently maculopathy and foveal retinoschisis33–36. 
Age of onset and severity are variable, affected individuals often presenting 
with early onset severe loss of vision with characteristic sub-retinal white dots, 
deep nummular pigmentary lesions and a thickened, disorganised retina with 
an undetectable ERG in the most severe cases4,37. It is of interest that the 
three individuals reported here resembled clinically those with CRB1-
retinopathy although the age of onset was later4, and this suggests that 
perturbation of this pathway produces a distinctive human retinal phenotype. 
The phenotypes of the murine Crb1 knockout, Crb1-/-, and naturally occurring 
Rd8 truncating mutant are characterised by disruption of AJ between Müller 
cells and photoreceptors at the OLM, photoreceptor dysplasia and 
consequent focal areas of disorganised lamination and degeneration, 
although the remaining retina provides functional vision22,38,39. The knock-in 
missense RP mutant CrbC249W has a late onset degenerative phenotype and 
can partially rescue the phenotype in Crb1-/- mice40.  
 
Mutation of the apical domain essential Crumbs complex proteins epb41l5 
(moe), mpp5a (nok) and crb2a (ome) in the zebrafish (mosaic eyes, nagie oko 
and oko meduzy respectively) all result in AB polarity defects leading to retinal 
dystrophy characterised by retinal developmental and lamination 
abnormalities41–45. Similarly, the larval lethal medaka fish retinal differentiation 
mutant (medeka [Japanese - large eyes]) exhibits disorganisation of retinal 
lamination during embryonic development consequent on a LOF mutation 
resulting in absence of the ArhGEF18 protein product29. The phenotype is 
consequent upon abrogation of ArhGEF18 activity in the developing embryo 
resulting in disruption of RHOA activation and perturbation of AB polarity 
characterised by mislocalisation of TJ, disorganisation of the actin 
cytoskeleton and cell proliferation morphology alterations.  
 
The disease mechanism of human ARHGEF18-retinopathy is not yet fully 
understood and may include developmental and/or degenerative 
mechanisms. Disruption of ARHGEF18 function in retinal development seems 
unlikely, as a severe early onset retinal dystrophy would be a more probable 
consequence and our three individuals all experienced normal visual function 
in early life. A more plausible hypothesis is that photoreceptors are peculiarly 
sensitive to the failure of AJ maintenance than other cells causing onset of 
retinal degeneration in adulthood. Similar clinical features and variable age of 
onset seen in CRB1-retinopathy strengthens the assertion that maintenance 
of this complex is required for continued photoreceptor viability in humans. 
The phenotypic similarity of ArhGEF18 and crumbs complex protein 
knockouts in lower vertebrates reflects the similarity of these in humans, 
Taken together these observations suggest other proteins essential in AB 
polarity maintenance should be regarded as candidate genes in retinal 
dystrophies. Furthermore, the pathway provides a target for therapeutic 
intervention with the potential to ameliorate visual impairment due to this type 
of retinal dystrophy.  
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Figure 1: Variant analysis of ARHGEF18 in individuals 1-3. A. Pedigrees and 
cosegregation of mutations M1-M5 in families 1-3. B. Schematic 
representation of mutation location in full length ARHGEF18 protein including 
DBL homology (DH) and Plekstrin homology (PH) domains. C. IGV 
visualisation of 150bp paired end reads spanning mutations ARHGEF18, 
c.2632G>T and c.2738_2761del in individual 2, showing biallelic state. D. 
Clustal Omega alignment of amino acid residues affected by M1 (missense) 
and M4 (inframe deletion) mutations throughout vertebrate orthologues. 
 
Figure 2: Retinal abnormalities in ARHGEF18 related retinal dystrophy. A. 
Color fundus photographs, 55 degree fundus autofluorescence imaging, and 
optical coherence tomography (OCT). Individual 1, right eye at age 38 years : 
A. optic disc pallor, peripheral retinal pigment epithelium (RPE) atrophy and 
nummular pigmentation; B. peripheral patchy reduction of autofluorescence; 
C. reasonably preserved retinal layers on OCT with disruption of the inner 
segment ellipsoid band and intra-retinal cysts within the inner nuclear layer. 
Individual 2, right eye at 48 years: D. disc pallor and vessels attenuation with 
RPE atrophy within the macula and mid-periphery as well as peripheral 
nummular and dot lesions of hyperpigmentation; E. extensive loss of 
autofluorescence in periphery and in a central ring in macula; F. loss of outer 
retina and RPE throughout the macula with small foci of preserved 
photoreceptors centrally. Individual 3, right eye at 37 years: G. vascular 
attenuation and occlusion, peripheral RPE atrophy, white dots and nummular 
pigmentation; H. loss of autofluorescence in periphery; I. reasonably 
preserved retinal layers on OCT with disruption of the inner segment ellipsoid 
band and intra-retinal cysts within the inner nuclear layer. 
 
Figure 3: Signalling activity of ARHGEF18 variants. HEK293T or HCE cells 
were transfected with cDNAs encoding wild type or mutant VSV-tagged 
ARHGEF18. A. Lysates of transfected HEK293T cells were assayed for 
RHOA-GTP levels by G-LISA assay, which measures binding of active RHOA 
to the GTPase binding domain of Rhotekin. B. Serum response element 
(SRE) element activity was measured using a double luciferase assay with an 
SRE-containing promoter driving firefly luciferase expression and a CMV 
promoter expression of renilla luciferase. Firefly to renilla luciferase ratios 
were calculated and normalized to a plasmid control performed by co-
transfecting an empty expression vector. The graphs show averages ± 1 
standard deviations, n=4, indicated are p-values from Anova and t-tests. C. 
Transfected HCE cells were fixed and stained with anti-VSV and anti-
phosphorylated myosin regulatory light chain (ppMLC) antibodies along Ato-
647-labelled phalloidin to visualize F-actin and imaged by epifluorescence. D. 
Cells transfected as in D were stained for the junctional markers alpha-catenin 
and Catenin delta-1 and imaged by confocal microscopy. Scale bars: C, 
20µm; D, 10µm.   
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Table S1: Summary of ARHGEF18 mutations 
 Individual Genomic coordinates 
(GRCh37) 
cDNA change 
(NM_001130955) 
Protein consequence 
M1 1 chr19:g.7509101A>G c.808A>G p.Thr270Ala 
M2 1 chr19:g.7527145C>T c.1996C>T p.Arg666* 
M3 2 chr19:g.7532286G>T c.2632G>T p.Glu878* 
M4 2 chr19:g.7532392_ 
7532415del 
c.2738_2761del p.Arg913_Glu920del 
M5 3 chr19:g.7521294G>A  c.1617+5G>A p.Asp540Glyfs*63 
Control N/A N/A c.1252_1253delTAinsGC p.Tyr418Ala 
(Control: GEF inactive mutant construct) 
 
Table S2: Rare variants observed in genes associated with IRD in individuals 1-3 
Individual HUGO Genotype HGVSc HGVSp EXAC_AF Disease inheritance Exclusion criteria 
1 GPR98 Heterozygous ENST00000405460.2:c.2288A>G 
ENSP00000384582.2:
p.Asp763Gly NA Recessive 
Heterozygous variant only/ 
does not fit phenotype 
1 NPHP3 Heterozygous ENST00000337331.5:c.1189C>T 
ENSP00000338766.5:
p.Arg397Cys 0.003303 Recessive 
Heterozygous variant only/ 
does not fit phenotype 
1 GUCA1B Heterozygous ENST00000230361.3:c.253G>A 
ENSP00000230361.3:
p.Val85Met 0.001359 Dominant 
ExAC MAF too high for 
dominant disease allele 
1 MYO7A Heterozygous ENST00000409709.3:c.3392A>G 
ENSP00000386331.3:
p.His1131Arg 0.000008411 Recessive 
Heterozygous variant only/ 
does not fit phenotype 
1 CDH23 Heterozygous ENST00000398788.3:c.1591G>A 
ENSP00000381768.3:
p.Gly531Ser 0.0004793 Recessive 
Heterozygous variant only/ 
does not fit phenotype 
1 PROM1 Heterozygous ENST00000510224.1:c.622delA 
ENSP00000426809.1:
p.Thr208LeufsTer23 0.00005793 
Dominant/re
cessive 
Biallelic LOF variants in 
PROM1 cause arRP - This 
individual is a carrier of a 
probable LOF allele in 
PROM1 
1 RP1 Heterozygous ENST00000220676.1:c.1118C>T 
ENSP00000220676.1:
p.Thr373Ile 0.013 
Dominant/re
cessive 
ExAC MAF too high for 
dominant disease allele 
2 PEX1 Heterozygous ENST00000248633.4:c.1276A>G 
ENSP00000248633.4:
p.Met426Val 0.000008237 Recessive 
Heterozygous variant only/ 
does not fit phenotype 
2 ABCC6 Heterozygous ENST00000205557.7:c.2836C>A 
ENSP00000205557.7:
p.Leu946Ile 0.011 Recessive Does not fit phenotype 
2 ABCC6 Heterozygous ENST00000205557.7:c.3507-3C>T   0.016 Recessive Does not fit phenotype 
2 MAK Heterozygous ENST00000313243.2:c.174T>G 
ENSP00000313021.2:
p.Asn58Lys 0.0002069 Recessive Heterozygous variant only 
2 HMX1 Heterozygous ENST00000400677.3:c.233G>A 
ENSP00000383516.3:
p.Gly78Asp NA Recessive Heterozygous variant only 
2 AHI1 Heterozygous 
ENST00000367800.4:
c.2961+7_2961+21del
TTATTTTATGCAGTTi
nsGACTTTTTTAAAG
TTTTAAA 
  NA Recessive Heterozygous variant only 
2 SLC24A1 Heterozygous ENST00000261892.6:c.2813T>G 
ENSP00000261892.6:
p.Val938Gly 0.000008276 Recessive 
Heterozygous variant only/ 
does not fit phenotype 
2 IDH3B Heterozygous ENST00000380851.5:c.1133C>T 
ENSP00000370232.5:
p.Ala378Val 0.00003295 Recessive Heterozygous variant only 
2 ARL13B Heterozygous ENST00000394222.3:c.1186C>G 
ENSP00000377769.3:
p.Pro396Ala 0.006466 Recessive 
Heterozygous variant only/ 
does not fit phenotype 
2 IMPDH1 Heterozygous ENST00000338791.6:c.1108G>A 
ENSP00000345096.6:
p.Ala370Thr 0.002224 Dominant 
ExAC MAF too high for 
dominant disease allele 
2 COL18A1 Heterozygous ENST00000359759.4:c.1210G>A 
ENSP00000352798.4:
p.Ala404Thr 0.001865 Recessive 
Heterozygous variant only/ 
does not fit phenotype 
2 IMPG2 Heterozygous ENST00000193391.7:c.3038C>T 
ENSP00000193391.6:
p.Pro1013Leu 0.003533 Recessive Heterozygous variant only 
2 BBS12 Heterozygous ENST00000542236.1:c.1190C>T 
ENSP00000438273.1:
p.Ala397Val 0.00001647 Recessive 
Heterozygous variant only/ 
does not fit phenotype 
2 PDE6A Heterozygous ENST00000255266.5:c.718-4dupT   0.002018 Recessive Heterozygous variant only 
2 CDHR1 Heterozygous ENST00000372117.3:c.1868A>G 
ENSP00000361189.3:
p.Asn623Ser 0.004093 Recessive Heterozygous variant only 
2 BBS2 Heterozygous ENST00000245157.5:c.1231A>G 
ENSP00000245157.5:
p.Ile411Val NA Recessive 
Heterozygous variant only/ 
does not fit phenotype 
3 ABCA4 Heterozygous ENST00000370225:exon9:c.1140T>A 
ENSP00000359245.3:
p.Asn380Lys 0.0004942 Recessive 
Heterozygous variant only/ 
does not fit phenotype 
3 GNAT2 Heterozygous ENST00000351050:exon8:c.896C>T 
ENSP00000251337.3:
p.Ala299Val 0.00004122 Recessive 
Heterozygous variant only/ 
does not fit phenotype 
3 USH2A Heterozygous ENST00000307340:exon15:c.3026C>G 
ENSP00000305941.3:
p.Ala1009Gly 0.000008347 Recessive Heterozygous variant only 
3 TRPM1 Heterozygous ENST00000397795:exon27:c.3841G>A 
ENSP00000380897.2:
p.Glu1281Lys 0.006526 Recessive 
Heterozygous variant only/ 
does not fit phenotype 
 
  
Table S3: Predicted biallelic rare variants observed in individual 1: 
CHR	 POSITION	 REFERENCE	 OBSERVED	 Genotype	 EXAC_AF	 HUGO	 CONSEQUENCE	 HGVSc	 HGVSp	
1	 33235594	 C	 T	 HET	 2.49E-05	 KIAA1522	 missense_variant	 ENST00000401073.2:c.814C>T	
ENSP00000383851.2:p.Arg272
Trp	
1	 33237743	 C	 G	 HET	 5.79E-05	 KIAA1522	 missense_variant	 ENST00000401073.2:c.2963C>G	 ENSP00000383851.2:p.Ser988Cys	
1	 53793511	 T	 A	 HOM	 0.0009537	 LRP8	 missense_variant	 ENST00000306052.6:c.74A>T	 ENSP00000303634.6:p.Gln25Le
u	
2	 189899700	 T	 A	 HET	 0.0004942	 COL5A2	 missense_variant	 ENST00000374866.3:c.4295A>T	 ENSP00000364000.3:p.Asp1432Val	
2	 189899755	 C	 T	 HET	 0.0009884	 COL5A2	 missense_variant	 ENST00000374866.3:c.4240G>A	 ENSP00000364000.3:p.Asp141
4Asn	
19	 7509101	 A	 G	 HET	 NA	 ARHGEF18	 missense_variant	 ENST00000359920.6:c.808A>G	
ENSP00000352995.4:p.Thr270
Ala	
19	 7527145	 C	 T	 HET	 NA	 ARHGEF18	 stop_gained	 ENST00000359920.6:c.1996C>T	 ENSP00000352995.4:p.Arg666
Ter	
22	 46654636	 G	 C	 HET	 0.0008484	 PKDREJ	 missense_variant	 ENST00000253255.5:c.4584C>G	
ENSP00000253255.5:p.Ile1528
Met	
22	 46658832	 C	 T	 HET	 NA	 PKDREJ	 missense_variant	 ENST00000253255.5:c.388G>A	 ENSP00000253255.5:p.Val130
Met	
 
  
Table S4: Predicted biallelic rare variants observed in individual 2: 
CHR	 POSITION	 REFERENCE	 OBSERVED	 Genotype	 EXAC_AF	 HUGO	 CONSEQUENCE	 HGVSc	 HGVSp	
2	 152376170	 A	 G	 HET	 0.0001159	 NEB	
splice_donor_varian
t	
ENST00000397345.3:c.22590+2T
>C	 		
2	 152584331	 T	 TGCTGGCTGTGCCAGA	 HET	 NA	 NEB	 inframe_insertion	
ENST00000397345.3:c.153_167d
upTCTGGCACAGCCAGC	
ENSP00000380505.3:p.Leu57_
Ala61dup	
3	 65425560	 TCTGCTGCT
G	
T	 HOM	 NA	 MAGI1	 inframe_deletion	 ENST00000402939.2:c.1255_126
3delCAGCAGCAG	
ENSP00000385450.2:p.Gln419
_Gln421del	
4	 187584530	 G	 A	 HOM	 0.004081	 FAT1	 missense_variant	 ENST00000441802.2:c.3503C>T	 ENSP00000406229.2:p.Ser1168Leu	
5	 77311370	 C	 T	 HET	 0.003805	 AP3B1	 missense_variant&s
plice_region_variant	
ENST00000255194.6:c.2995G>A	 ENSP00000255194.6:p.Val999
Met	
5	 77461466	 C	 G	 HET	 0.0005687	 AP3B1	 missense_variant	 ENST00000255194.6:c.1198G>C	
ENSP00000255194.6:p.Ala400P
ro	
7	 100674881	 G	 A	 HET	 0.0002586	 MUC17	 splice_acceptor_vari
ant	
ENST00000306151.4:c.185-1G>A	 	n/a	
7	 100685397	 G	 A	 HET	 0.0001071	 MUC17	 missense_variant	 ENST00000306151.4:c.10700G>A	
ENSP00000302716.4:p.Arg356
7His	
8	 21974516	 C	 T	 HET	 0.0006927	 HR	 missense_variant	 ENST00000381418.4:c.3250G>A	 ENSP00000370826.4:p.Ala1084
Thr	
8	 21978273	 G	 A	 HET	 0.0004436	 HR	 missense_variant	 ENST00000381418.4:c.2566C>T	
ENSP00000370826.4:p.Arg856
Trp	
12	 58016602	 AGCTGCCCAGGATTCTG	 A	 HET	 0.001812	 SLC26A10	 frameshift_variant	
ENST00000320442.4:c.829_844d
elCCCAGGATTCTGGCTG	
ENSP00000320217.4:p.Pro277
ThrfsTer138	
12	 58016690	 G	 C	 HET	 0.001738	 SLC26A10	 missense_variant	 ENST00000320442.4:c.912G>C	
ENSP00000320217.4:p.Lys304
Asn	
12	 58016890	 T	 G	 HET	 0.003328	 SLC26A10	 missense_variant	 ENST00000320442.4:c.1023T>G	 ENSP00000320217.4:p.Asn341Lys	
14	 45711988	 C	 A	 HET	 0.003706	 MIS18BP1	 missense_variant	 ENST00000310806.4:c.634G>T	
ENSP00000309790.4:p.Ala212S
er	
14	 45712000	 G	 C	 HET	 0.0007413	 MIS18BP1	 missense_variant	 ENST00000310806.4:c.622C>G	 ENSP00000309790.4:p.Gln208Glu	
14	 102900798	 T	 G	 HET	 0.0009748	 TECPR2	 missense_variant	 ENST00000359520.7:c.1644T>G	 ENSP00000352510.7:p.Asn548
Lys	
14	 102916165	 C	 T	 HET	 0.00411	 TECPR2	 missense_variant	 ENST00000359520.7:c.3275C>T	 ENSP00000352510.7:p.Ser1092Leu	
16	 16255424	 G	 A	 HET	 0.016	 ABCC6	 splice_region_varia
nt&intron_variant	
ENST00000205557.7:c.3507-
3C>T	
	n/a	
16	 16263662	 G	 T	 HET	 0.011	 ABCC6	 missense_variant	 ENST00000205557.7:c.2836C>A	 ENSP00000205557.7:p.Leu946Ile	
16	 23646857	 A	 G	 HOM	 0.014	 PALB2	 missense_variant	 ENST00000261584.4:c.1010T>C	 ENSP00000261584.4:p.Leu337
Ser	
16	 31475712	 C	 A	 HET	 0.0002853	 ARMC5	
splice_region_varia
nt&intron_variant	
ENST00000268314.4:c.1371-
3C>A	 	n/a	
16	 31477594	 C	 G	 HET	 0.001536	 ARMC5	 missense_variant	 ENST00000268314.4:c.2192C>G	 ENSP00000268314.4:p.Pro731
Arg	
16	 88782205	 G	 C	 HET	 0.0009697	 PIEZO1	 missense_variant	 ENST00000301015.9:c.7374C>G	
ENSP00000301015.9:p.Phe245
8Leu	
16	 88789499	 G	 A	 HET	 0.001903	 PIEZO1	 splice_region_varia
nt&intron_variant	
ENST00000301015.9:c.4495+4C>
T	
	n/a	
16	 88798919	 G	 T	 HET	 0.0009696	 PIEZO1	 missense_variant	 ENST00000301015.9:c.2815C>A	
ENSP00000301015.9:p.Leu939
Met	
17	 55183792	
GGCTTGGAT
AGAAATGA
GGAGA	
G	 HOM	 NA	 AKAP1	 inframe_deletion	 ENST00000337714.3:c.988_1008
delAGCTTGGATAGAAATGAGGAG	
ENSP00000337736.3:p.Ser330_
Glu336del	
19	 7532286	 G	 T	 HET	 NA	 ARHGEF18	 stop_gained	 ENST00000359920.6:c.2632G>T	 ENSP00000352995.4:p.Glu878
Ter	
19	 7532386	
GCGAGCGG
CTGGAGCA
GGAGCGGG
C	
G	 HET	 NA	 ARHGEF18	 inframe_deletion	
ENST00000359920.6:c.2738_276
1delGGCTGGAGCAGGAGCGGGCC
GAGC	
ENSP00000352995.4:p.Arg913
_Glu920del	
19	 8130867	 G	 T	 HET	 0.002926	 FBN3	 missense_variant	 ENST00000600128.1:c.8366C>A	
ENSP00000470498.1:p.Pro278
9Gln	
19	 8138104	 C	 T	 HET	 0.003295	 FBN3	 missense_variant	 ENST00000600128.1:c.7780G>A	 ENSP00000470498.1:p.Val2594Ile	
22	 46760604	 C	 T	 HET	 0.0003229	 CELSR1	 missense_variant	 ENST00000262738.3:c.8584G>A	
ENSP00000262738.3:p.Gly286
2Ser	
22	 46762275	 G	 A	 HET	 1.67E-05	 CELSR1	 splice_region_variant&intron_variant	
ENST00000262738.3:c.8300+8C>
T	 n/a	
 
  
Table S5: Predicted biallelic rare variants observed in individual 3: 
CHR	 POSITION	 REFERENCE	 OBSERVED	 Genotype	 EVS	MAF	 HUGO	 Exonic	Function	 AAChange	 	
1	 158908291	 C	 G	 HET	 NA	 PYHIN1	 nonsynonymous	
SNV	
ENST00000368140:c.370C>G	 ENSP00000357122.9:p.Arg124
Gly	
1	 158908881	 A	 C	 HET	 0.000154	 PYHIN1	
nonsynonymous	
SNV	 ENST00000368140:c.423A>C	
ENSP00000357122.9:p.Lys141
Asn	
8	 31001099	 T	 A	 HOM	 NA	 WRN	 nonsynonymous	
SNV	
ENST00000298139:c.3343T>A	 ENSP00000298139.5:p.Cys111
5Ser	
12	 114387907	 T	 A	 HOM	 0.001922	 RBM19	
nonsynonymous	
SNV	 ENST00000261741:c.1053A>T	
ENSP00000261741.5:p.Lys351
Asn	
19	 7521294	 G	 A	 HOM	 NA	 ARHGEF18	 		 ENST00000359920:c.1617+5G>A	 n/a	
19	 8175953	 C	 T	 HET	 0.001153	 FBN3	
nonsynonymous	
SNV	 ENST00000270509:c.4199G>A	
ENSP00000270509.2:p.Arg140
0Gln	
19	 8188682	 C	 T	 HET	 0.001008	 FBN3	 nonsynonymous	
SNV	
ENST00000270509:c.2942G>A	 ENSP00000270509.2:p.Arg981
Gln	
22	 21044431	 G	 A	 HOM	 NA	
POM121L4
P	
nonsynonymous	
SNV	 ENST00000412250:c.113G>A	 n/a	
22	 22042011	 G	 A	 HOM	 0.000308	 PPIL2	 nonsynonymous	
SNV	
ENST00000335025:c.977G>A	 ENSP00000334553.8:p.Arg326
Gln	
 
Table S6: Additional biallelic rare (ExAC MAF≤0.005) variants of unknown significance in ARHGEF18 present in 4 individuals with 
unrelated phenotypes in the UCL exome cohort of 5695 individuals.  
Individual dbSNP Genomic coordinates 
(GRCh37) 
cDNA change 
(NM_001130955) 
Protein 
consequence 
Genotype Homozygous 
individuals in 
gnomad 
dataset 
Causative 
mutation 
identified 
SIFT, 
Polyphen2 
prediction 
A rs375852625 chr19:g.7505169G>A c.343G>A p.Gly115Arg homozygous 0 no D, PD 
B rs200483329 chr19:g.7516147C>T c.1286C>T p.Thr429Met homozygous 0 yes D, PD 
C rs28489511 chr19:g.7505332C>A c.506C>A p.Pro169Gln heterozygous 13 no T, B 
C rs74497723 chr19:g.7506936A>T c.794A>T p.Tyr265Phe heterozygous 9 no T, B 
D rs368588291 chr19:g.6516071G>A c.1210G>A p.Val404Leu homozygous 0 yes D, Poss D 
D=Damaging, PD=Probably Damaging, T=Tolerated, B=Benign, Poss D=Possibly Damaging 
 
 
 
 
Table S7: Clinical summary 
Individual,  
family 
number 
Age of onset, 
years, symptoms 
Age at last 
review 
(length of 
review), years 
Presenting 
VA logMAR 
(Snellen) 
Latest VA 
logMAR 
(Snellen) 
Latest 
refractive error, 
dioptres 
Fundus features Age at last 
electrophysiology, 
key findings 
Colour vision Visual fields Other findings 
Individual 1 
GC18203 
20 yrs reduced 
acuity, mild 
nyctalopia, blind 
spots 
 37 (8) R 0.3 
(20/40)  
L 0.18 
(20/30) 
R 0.6 
(20/80)  
L 0.6 
(20/80) 
R 0/-0.50 x 100  
L +1.00/-0.75 x 
110 
Irregular peripheral 
pigment, pale discs, 
cystoid macular edema, 
vitreous opacities, 
attenuated sheathed 
vessels, peripheral retinal 
exudate 
30, subnormal PERG, 
rod specific ERG 
markedly subnormal, 
bright flash subnormal 
with unusual bifid b 
waves, cone specific 
delayed and 
subnormal; profound 
rod>cone dysfunction 
Ishihara age 
29 R 17/17 L 
13/17 
Octopus visual 
fields age 36 
central 20-30 
degrees retained 
on R , 30-50 
degrees on L, 
age 37 24-2 
central 
scotomas, fields 
now constricted 
to 15 degrees 
each eye 
Nil else 
Individual 2 
GC3626 
29, photopsia, 
slightly reduced 
acuity, mild 
nyctalopia 
51 (22) R 0.48 
(20/60)  
L 0.3 (20/40) 
R 1.8 
(20/1250)  
L 1.5 
(20/630)   
R -1.00/-1.00 x 5  
L +0.75/-1.00 x 
90 
Irregular pigmented 
lesions in periphery, pale 
discs, cystoid macular 
edema, peripheral 
telangiectasia with some 
retinal edema and vitreous 
cells, possible para-
arteriolar sparing 
29, no identifiable 
responses other than 
a minimal, delayed 
response to 30Hz 
flicker (PERG, EOG 
and ERG tested); 
severe photoreceptor 
dysfunction 
Ishihara age 
29 15/15 each 
eye 
Goldmann visual 
fields age 29: 
ring scotoma at 
30 degrees, 
binocular 
Esterman age 
36: central 20 
degrees only  
retained 
L Fuch’s 
heterochromic 
cyclitis 
Individual 3 
GC17880 
30, photopsia, 
nyctalopia and 
field defects 
38 (8) R 0.18 
(20/30)  
L 0.48 
(20/60) 
R 0.18 
(20/30)  
L 0.8  
(20/125)  
R +2.25/-1.00 x5  
L +2.00/-1.50 x 
165  
Irregular pigmented 
lesions in periphery, 
foveal/parafoveal cysts  
30, PERG borderline 
on R, subnormal on L, 
undetectable rod 
ERG, abnormal cone 
ERG; severe 
rod>cone dysfunction 
Ishihara age 
33 R 21/23 L 
3/23 
Fields to 
confrontation 
age 36 years 
less than 30 
degrees 
 
Left band 
keratopathy 
Wolf-Parkinson 
White syndrome, 4 
miscarriages 
 
 Figure S1: Full-field and pattern ERGs in individuals 1 and 3. DA: dark 
adapted; LA: light adapted. The numbers refer to flash strength (cd.s/m2). The 
dim flash, rod-system specific ERG is severely reduced in individual 1; 
undetectable in individual 3. The bright flash DA 10 ERG is markedly 
subnormal in individual 1, and has a b-wave of lower amplitude than the a-
wave in individual 3, perhaps suggesting the response to be arising in dark 
adapted cones in the absence of rod dunction.30Hz flicker ERG is markedly 
reduced and delayed in individual 1; markedly reduced and of altered 
waveform in individual 3. Photopic single flash cone ERGs in both individuals 
are markedly subnormal and mildly delayed. PERG is mildly subnormal in 
both individuals. The findings are those of moderately severe (individual 1) or 
severe (individual 3) rod>cone dysfunction with macular involvement. Note 
difference in ERG amplitude scale in affected individuals compared with the 
representative normal traces. 
 
 
 
Figure S2: RT-PCR analysis of predicted splice-altering variants identified in 
ARHGEF18. A: Altered splicing due to c.1617+5G>A resulting in mixed 
transcripts comprising skipped exon 8 and wildtype (WT)(lane 3), L= ladder, 
WT= control RNA sample. B: Sanger sequencing of upper (top) and lower 
(bottom) bands from lane 3 showing normal splicing and skipping of exon 8 
respectively. C: Mixed transcripts (lane 2) comprising c.2632G>T and 
c.2738_2761del alleles showing no splice alteration. D: Sanger sequencing of 
lane 2 band showing mixed alleles with heterozygous deletion of 24 
nucleotides corresponding to c.2738_2761del. 	
